yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q34261526-81D3E73F-3A82-413D-BE80-032A4F060E28
Q34261526-81D3E73F-3A82-413D-BE80-032A4F060E28
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34261526-81D3E73F-3A82-413D-BE80-032A4F060E28
Exclusive antagonism of the α4 β7 integrin by vedolizumab confirms the gut-selectivity of this pathway in primates.
P2860
Q34261526-81D3E73F-3A82-413D-BE80-032A4F060E28
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34261526-81D3E73F-3A82-413D-BE80-032A4F060E28
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0f502684770e63377252fdac7b126570cbc8ad85
P2860
Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab.